Mustafa Raoof (@mustafaraoofmd) 's Twitter Profile
Mustafa Raoof

@mustafaraoofmd

Cancer surgeon and researcher @cityofhope interested in pancreas, bile duct, liver and peritoneal cancers. Studying #replicationstress #DNAdamageresponse

ID: 726861731171954688

linkhttps://www.cityofhope.org/mustafa-raoof calendar_today01-05-2016 19:51:55

2,2K Tweet

1,1K Takipçi

704 Takip Edilen

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Upfront resection vs no resection of the primary tumor in metastatic colorectal cancer Annals of Oncology doi.org/10.1016/j.anno… 🔎Phs 3 CAIRO4, 206 pts 👉mOS 18.3 vs 20.1 mo 👉AEs ≥3° 72% vs 65% 🧐Upfront PTR to palliative systemic therapy does not improve survival ESMO - Eur. Oncology

Upfront resection vs no resection of the primary tumor in metastatic colorectal cancer
<a href="/Annals_Oncology/">Annals of Oncology</a> 
doi.org/10.1016/j.anno…
🔎Phs 3 CAIRO4, 206 pts
👉mOS 18.3 vs 20.1 mo
👉AEs ≥3°  72% vs 65%
🧐Upfront PTR to palliative systemic therapy does not improve survival
<a href="/myESMO/">ESMO - Eur. Oncology</a>
City of Hope (@cityofhope) 's Twitter Profile Photo

Researchers at City of Hope are advancing treatment for advanced prostate cancer with immunotherapy. Early results from a phase 1 trial using CAR T cell therapy showed minimal side effects and promising activity, as reported in Nature Medicine. cityofhope.org/study-car-t-pr…

Researchers at City of Hope are advancing treatment for advanced prostate cancer with immunotherapy. Early results from a phase 1 trial using CAR T cell therapy showed minimal side effects and promising activity, as reported in <a href="/NatureMedicine/">Nature Medicine</a>. cityofhope.org/study-car-t-pr…
Mustafa Raoof (@mustafaraoofmd) 's Twitter Profile Photo

Last call: July 19th Friday is the last date for registration. Only few spots remain! Looking forward to seeing everyone at the course

M. Talha Waheed (@mtalhawaheed) 's Twitter Profile Photo

PIPAC-Ox vs. 3rd-line standard therapy for CRC & AC carcinomatosis in Annals of Surgical Oncology Promising future for PIPAC ⬆️ Good days- days alive & outside 🏥 ⬆️ OS- 11.3 vs. 5.1 mo ⬆️ PFS- 2.9 vs. 2.1 mo: NS Next step ❓Randomized Trial ! Mustafa Raoof Thanh Dellinger City of Hope Surgical Oncology

PIPAC-Ox vs. 3rd-line standard therapy for CRC &amp; AC carcinomatosis in <a href="/AnnSurgOncol/">Annals of Surgical Oncology</a> 

Promising future for PIPAC

⬆️ Good days- days alive &amp; outside 🏥 
⬆️ OS- 11.3 vs. 5.1 mo
⬆️ PFS- 2.9 vs. 2.1 mo: NS

Next step ❓Randomized Trial !

<a href="/MustafaRaoofMD/">Mustafa Raoof</a> <a href="/TDellingerMD/">Thanh Dellinger</a> <a href="/COH_SurgOnc/">City of Hope Surgical Oncology</a>
CancerNetwork® (@cancernetwrk) 's Twitter Profile Photo

Future research will aim to assess the efficacy of PIPAC-MMC plus systemic therapy vs systemic therapy alone in patients with peritoneal tumors. #crcsm | Mustafa Raoof hubs.li/Q03f_D0_0

City of Hope (@cityofhope) 's Twitter Profile Photo

On the next episode of On the Edge of Breakthrough: Voices of Cancer Research, City of Hope surgical oncologist Dr. Mustafa Raoof and Sumanta K. Pal, MD, FASCO discuss emerging surgical techniques in pancreatic and peritoneal cancers. Stream the episode tomorrow on Apple Podcasts and Spotify!

Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

Our latest episode of the City of Hope podcast is out!!! Was delighted to interview the one & only Mustafa Raoof, who is developing an international reputation for innovative techniques like #PIPAC. We dive deep into the mind of a surgeon-scientist - have a listen! Yuman Fong

City of Hope (@cityofhope) 's Twitter Profile Photo

City of Hope researchers used an investigational City of Hope-developed drug, AOH1996, to target transcription-replication conflicts in pancreatic cancer. In a study just published in Gastroenterology, two participants saw liver metastases shrink by up to 49%. bit.ly/42BHN2b

City of Hope researchers used an investigational City of Hope-developed drug, AOH1996, to target transcription-replication conflicts in pancreatic cancer. In a study just published in <a href="/AGA_Gastro/">Gastroenterology</a>, two participants saw liver metastases shrink by up to 49%. bit.ly/42BHN2b
Anna Berkenblit, MD, MMSc (@aberkenblit) 's Twitter Profile Photo

Excited to see this PanCAN-funded study published in Gastroenterology, highlighting an investigational approach currently being evaluated in patients with #pancreaticcancer. Congratulations to Mustafa Raoof and the team at @CityofHope on this important advancement!

M Murtaza (@murtazamdphd) 's Twitter Profile Photo

new results from our lab at #AACR25 next week: Muhammad Talha Nawaz will show how peritoneal fluid tumor DNA (yes, ptDNA) can help detect and monitor response to therapy in patients with peritoneal metastasis, collaboration with Mustafa Raoof abstractsonline.com/pp8/#!/20273/p…

Raghav Sundar (@sundar__raghav) 's Twitter Profile Photo

Published today simultaneously with #AACR25 our work on colorectal cancer peritoneal metastases in Clinical Cancer Research. aacrjournals.org/clincancerres/… slowly heading toward the goal of treating this difficult disease with novel therapeutics

Published today simultaneously with #AACR25  our work on colorectal cancer peritoneal metastases in Clinical Cancer Research. aacrjournals.org/clincancerres/… slowly heading toward the goal of treating this difficult disease with novel therapeutics